Related Experiment Video
Updated: Jul 20, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
USP13 ameliorates myocardial infarction injury by inhibiting ferroptosis via stabilizing ALDOA
Pengcheng Li1, Delong Chen1, Chenyun Zhang1
1Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China; State Key Laboratory of Transvascular Implantation Devices, Hangzhou, 310009, China; Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Hangzhou, 310009, China.
Abstract:
Despite the central role of deubiquitinases (DUBs) in maintaining protein homeostasis, their important role in post-myocardial infarction (MI) remodeling remains incompletely characterized. Our study identifies a DUB, ubiquitin-specific protease 13 (USP13), as a stress-responsive regulator exhibiting significant downregulation in MI-induced cardiac injury. USP13 deficiency aggravated cardiac ferroptosis and cardiac dysfunction after MI surgery. Mechanistically, USP13 directly bound to fructose-bisphosphate aldolase A (ALDOA) via its ubiquitin-specific protease domain. USP13 regulated K48-linked deubiquitination and the stability of ALDOA at K13, thereby preventing its degradation via the proteasomal pathway and restraining ferroptosis in cardiomyocytes. Moreover, specifical overexpression the endogenous USP13 in mouse hearts attenuated MI-induced cardiac injury. We confirmed that USP13 inhibited MI-induced cardiac injury by deubiquitinating and stabilizing ALDOA. These findings suggest that USP13 may serve as a promising therapeutic target for myocardial infarction, providing a foundation for developing novel treatment strategies focused on ferroptosis.
More Related Videos
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024